May 23, 2023
Scientific retreat underscores impact and promise of cancer center’s research
UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.
Tag: Benjamin Vincent
November 14, 2022
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
October 6, 2022
Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
March 22, 2022
Loved ones battling cancer inspire donor’s gift
After seeing friends and family members struggle with cancer and tired of feeling helpless, Betsy Jordan decided to do something about it by making a gift to support innovative research.
March 15, 2022
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.
October 13, 2021
Susan G. Komen announces $1.5 million in grants for metastatic breast cancer research
Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
September 10, 2021
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.
August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
June 24, 2020
AACR honors The Cancer Genome Atlas researchers with 2020 Team Science Awards
UNC Lineberger faculty have held leadership and team membership roles with The Cancer Genome Atlas, which was launched in 2006.
June 3, 2019
Study co-led by Vincent published in Immunity’s ‘Best of 2018’
UNC Lineberger’s Benjamin Vincent, MD, an assistant professor in the UNC School of Medicine Division of Hematology/Oncology, was co-corresponding author of a study included in the journal Immunity’s “Best of 2018” reprint collection. Jonathan Serody, MD, UNC Lineberger’s associate director for translational sciences and the Elizabeth Thomas Professor of Medicine, Microbiology and Immunology in the …